As of June 2023 Swedish Orphan Biovitrum has a market cap of $5.87 Billion. This makes Swedish Orphan Biovitrum the world's 2149th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $5.87 B | -4.34% |
2022 | $6.14 B | 1.76% |
2021 | $6.03 B | 0.95% |
2020 | $5.98 B | 22.93% |
2019 | $4.86 B | -16.12% |
2018 | $5.80 B | 58.26% |
2017 | $3.66 B | 15.88% |
2016 | $3.16 B | -26.16% |
2015 | $4.28 B | 56.91% |
2014 | $2.73 B | -1.32% |
2013 | $2.76 B | 85.28% |
2012 | $1.49 B | 515.96% |
2011 | $0.24 B | -60.28% |
2010 | $0.61 B | 52.82% |
2009 | $0.39 B | 43.16% |
2008 | $0.27 B | -48.04% |
2007 | $0.53 B | -29.28% |
2006 | $0.75 B |
On Jun 1st, 2023 the market cap of Swedish Orphan Biovitrum was reported to be: